Testosterone and Alendronate in Hypogonadal Men

PHASE2TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

December 31, 2014

Conditions
HypogonadismOsteopeniaOsteoporosis
Interventions
DRUG

Testosterone

Testosterone Gel (Fortesta) 40mg daily.

DRUG

Alendronate

Alendronate (Fosamax) 70mg every week.

DRUG

Placebo Alendronate

A placebo alendronate tablet will be taken every week by subjects in the Testosterone and Placebo Alendronate Group.

DRUG

Placebo Testosterone

Placebo testosterone gel will be applied daily by subjects in the Alendronate and Placebo Testosterone group.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Endo Pharmaceuticals

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Massachusetts General Hospital

OTHER